Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. - Wikidata - awgldk - TriplyDB

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

http://www.wikidata.org/entity/Q36194959

about

Pathological outcomes and strategies to achieve optimal cancer control during robotic radical prostatectomy in Asian-Indian men Emerging critical role of molecular testing in diagnostic genitourinary pathology MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens Pathology in prostate research: optimizing the pathological data.Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy Perineural invasion is an independent predictor of outcome in colorectal cancer.Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling.Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique.Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome.Handling of radical prostatectomy specimens.Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy.Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies.Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.The association between tumour density and prostate cancer recurrence following radical prostatectomy.Prognosis of prostate cancer with other primary malignancies.Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance.The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy Prostate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers.The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical Prostatectomy.Expression of neutral endopeptidase, endothelin-1, and nuclear factor kappa B in prostate cancer: interrelations and associations with prostate-specific antigen recurrence after radical prostatectomy.Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score.Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomy.The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer.Prognostic significance of histopathological features of extraprostatic extension of prostate cancer.

P2860

Q24635051-38100FA8-7A45-4E04-816C-02C35069DC7B Q27021371-D780ED57-BBB8-4A70-8A1B-811C93663814 Q28478930-3331E4CA-23E3-4C37-86DF-D922B2F93388 Q33361134-6BB5594F-8A17-4E43-AEA1-0BFE15A08F01 Q33747053-7113BC54-D349-4CBF-89CC-1EE40E1F0B66 Q33909029-21418444-45C4-4343-B8FF-0693BADC6B57 Q34028208-13F137A2-8570-4BB8-A560-608ACC5A8B37 Q34293280-62C927D4-DDB5-41F7-B473-6378E3E14F05 Q34611646-2720F254-77E9-4E68-91AC-2BB7799C6D85 Q35033755-6F8C0208-5D5C-419A-9DD9-5ADBF1E4E810 Q36147719-1F462DC0-37C3-4E34-94DB-AFBFFE8D6581 Q36235443-8F2CC817-095C-4B16-B26E-704997D74816 Q37518609-E85FCFCA-7ACC-45D2-8802-85F370E31894 Q37781683-63AC40BC-DE31-4B96-BBFD-7EE52F2F264F Q37785485-E383C3E6-ECC6-426C-B563-81457AF337E6 Q37787737-FBFBCE5D-462F-49EB-A098-469C0C1271BA Q37819234-16DF5262-91BA-40EF-9743-265A603A9CE1 Q37934734-08185B59-5A55-4D24-B0E9-84DCF383C932 Q37934976-9E175B3D-5585-434B-93FB-FD829DB147E3 Q37972701-1ACD9B9B-425F-47BE-AE56-BAEDAF9977EB Q38067446-02FA0F71-6714-4C7D-97C8-39F904A079F5 Q38384899-E7EE0157-6377-422D-A1A5-4B50764DFE3D Q38916152-8E0A4EFD-7B94-4744-B46E-45BDD5DDBC1B Q39350465-DE6E86B5-51EC-468E-B917-F10705DE2CFE Q39717982-8DED63E6-5B6C-49BF-816C-9BF4038C4316 Q39757011-556FBBA0-17F1-4599-BDF8-A7E11ACF8E79 Q40708373-E49698FE-93E6-4DCD-8219-381A911ECDD3 Q41063995-681C3414-79E4-46BE-8903-752969A6A633 Q41120495-77EA80BD-A537-4340-9C18-D0C141DEFB72 Q41342281-A4A612F2-5CCD-4D63-AD4E-E6CC3135897C Q41435839-61631B83-93D4-4E88-9F90-04442C462B03 Q41837254-46E2E368-C345-4E33-B73A-668C69841C4F Q41847322-B459C40B-D1BF-425C-805F-20AB181BD9C2 Q41854285-F9C27307-03B4-4138-A92F-4711B117327D Q42126017-B31658C4-3CF8-4610-994C-9D03008B48B0 Q42139633-B63DE900-7107-455B-8832-99AEF0AE0767 Q42140991-81841667-7BC2-41B8-969D-6EB775A4DB51 Q42614060-25BE56BB-873D-4E74-940C-993B79C4B31A Q43650830-D30141C9-BEF8-4BAE-8581-01AFA9076EB9 Q43923266-BD5233DA-5869-45E7-B024-92AC6600ABAC

P2860

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

http://www.wikidata.org/entity/Q36194959

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@ast

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@en

type

label

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@ast

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@en

prefLabel

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@ast

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@en

P1433

Q36194959-1199D007-C6C9-4D18-9A8A-B83FD3354D4B

P1476

Q36194959-F54FB4E8-129E-43CD-9031-84F502384281

P2093

Q36194959-053422EA-C200-4EB0-8973-1CF1E24C48D1

Q36194959-29BC3E56-0919-4C0E-AF7B-A3EBA34818E9

Q36194959-4B10F2DC-E51D-4554-8A22-53A75564B4C2

Q36194959-88FA99A8-015D-46B2-A6A5-83822B0AA45D

Q36194959-98A6F85C-69C8-47FA-A96B-BC32516489D4

Q36194959-A6DD9281-4DD8-4166-899D-3D70A4F2992E

Q36194959-A7647929-A551-4681-9127-326D9A02E5FB

Q36194959-AB3F6C38-2E3F-467F-AF5A-382D470EE491

Q36194959-C63D1623-9822-433B-920E-B2E584689EAF

Q36194959-E900DA33-2193-4840-980D-B710FF8DE174

P2860

Q36194959-0D9B13A6-9793-48EF-BD6C-C1C056CBCA0C

Q36194959-14430DB4-BEBF-4268-A830-768EFD41280E

Q36194959-1D7D0D4B-6289-4458-8F30-9DA3270BBF73

Q36194959-288392E3-C4DB-4D96-BAF3-5DD35DE6DFE0

Q36194959-2F2AB6E9-EC75-415B-927B-705103DC6B0A

Q36194959-36022D9F-AD02-41E1-B835-FCE61DF349CB

Q36194959-44A1ED19-1EA8-4B0E-99EE-91C7E2D2D690

Q36194959-50ACC349-AE9E-432B-898E-069D327947E4

Q36194959-58C8C902-2B5B-4BFC-8CD1-24C32FB6C0BA

Q36194959-5B6FEBEE-2CBB-4F54-9D35-DDAF06DB8D31

P304

Q36194959-3569E83F-4ED4-4BBE-A495-B0648173BFEC

P31

Q36194959-42BEC614-2537-43F7-BAFC-CCF1E9A2C8B3

P356

Q36194959-E375243D-5B8A-43A4-8210-723B131B317E

P433

Q36194959-E5377F1D-6623-4E68-A583-67A038FABFFE

P50

Q36194959-CCFEF2D4-9E4D-46BC-880A-2CA65202237B

P577

Q36194959-CAD41179-9F5A-4E61-83CD-F006BEBF0EFD

P698

Q36194959-981B91B4-6184-48E2-813E-475EEF0BAA24

P921

Q36194959-7FB73F5B-4A63-4C7A-A118-E51A64D9C862

P356

03008880510030932

P1433

Scandinavian Journal of Urology and Nephrology. Supplement

P1476

Prognostic factors and reporti ...... vic lymphadenectomy specimens.

@en

P2093

Don Newling

http://www.w3.org/2001/XMLSchema#string

Gregor Mikuz

http://www.w3.org/2001/XMLSchema#string

John R Srigley

http://www.w3.org/2001/XMLSchema#string

Jonathan I Epstein

http://www.w3.org/2001/XMLSchema#string

Lars Egevad

http://www.w3.org/2001/XMLSchema#string

Liliane Boccon-Gibod

http://www.w3.org/2001/XMLSchema#string

Mahul Amin

http://www.w3.org/2001/XMLSchema#string

Peter A Humphrey

http://www.w3.org/2001/XMLSchema#string

Sten Nilsson

http://www.w3.org/2001/XMLSchema#string

Thomas M Wheeler

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of morphometric measurements of prostate carcinoma volume

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

Morphologic and molecular prognostic markers in prostate cancer.

Failure after radical prostatectomy.

Positive margins after laparoscopic radical prostatectomy: a prospective study of 100 cases performed by 4 different surgeons.

Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread.

Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy.

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.

Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens.

P304

34-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/03008880510030932

http://www.w3.org/2001/XMLSchema#string

P433

216

http://www.w3.org/2001/XMLSchema#string

P50

Rodolfo Montironi

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16019758

http://www.w3.org/2001/XMLSchema#string

P921

lymphadenectomy